GlassScriptPhysician profile
Angela Nicolini
NPI 1013446228
$1,462.50
in general payments reported to CMS, 2019-2025
16 companies · $412 in 2025
The $412 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $65.18 · 2023: $553 · 2024: $432 · 2025: $412.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $315.83 | 2023-2025 | Breztri, Airsupra |
| Novo Nordisk INC | $258.42 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $191.26 | 2023-2025 | Shingrix, Arexvy, Bexsero |
| Pfizer INC. | $176.51 | 2023-2025 | |
| Lilly USA, LLC | $161.75 | 2024-2025 | Mounjaro, Zepbound |
| Abbott Laboratories | $68.54 | 2025 | Freestyle Libre 3 |
| Idorsia Pharmaceuticals US INC | $68.02 | 2023-2024 | Quviviq |
| Exact Sciences Corporation | $40.35 | 2025 | Cologuard Collection Kit |
| Becton, Dickinson and Company | $30.66 | 2024 | |
| Ucb, INC. | $29.95 | 2023 | Fintepla |
| Biogen, INC. | $29.18 | 2023 | Tysabri, Vumerity |
| Eisai INC. | $23.96 | 2023 | |
| Amgen INC. | $21.43 | 2024 | Repatha, Otezla |
| Sk Life Science, INC. | $16.77 | 2023 | |
| Astellas Pharma US INC | $16.22 | 2024 | Veozah |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $13.65 | 2023 | Nourianz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Nicolini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.